Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02399306Phase 3Completed
Phase 3, randomised, open-label trial (2 arms), sponsored by Sichuan Cancer Hospital. Primary endpoint: Body Weight Change from baseline to the end of treatment. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02399306.